Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cortexin domain containing 1 (CTXND1) is a human protein-coding gene predicted to be located in the membrane and has been associated, at the level of prediction or correlation, with gastric cancer[1][6][9]. There is sparse information regarding its detailed molecular function, mechanisms, or any validated therapeutic targeting—additionally, it has previously been designated as a long non-coding RNA (LINC01314) in older resources, further adding to ambiguity in functional annotation[1][2][3][5]. As such, it is not recognized as a classical therapeutic target such as a receptor, enzyme, or transporter, and both its biological function and molecular classification remain largely uncharacterized in the literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cortexin domain containing 1 (CTXND1).